Abstract
Taurine (2-aminoethanesulfonic acid) is a natural amino acid that is found widely in all mammalian tissues. Several studies have demonstrated that taurine has anti-inflammatory, antioxidant, and hypoglycemic effects. Recently, taurine not only mitigates the side effects of chemotherapy in cancer but also possesses antitumor properties, including inhibiting cancer cell proliferation and inducing apoptosis in certain cancers by differential regulating proapoptotic and antiapoptotic proteins. Antitumor studies of taurine are still in their infancy, and the mechanism of its antitumor effect is not fully understood. In this regard, it is worthwhile to study the antitumor mechanism of taurine, which may provide clues to develop new synthetic therapeutic molecules. In this mini review, we summarize the main effects of taurine that have shown suppressing actions in the initiation and progression of cancers. The underlying molecular mechanism also suggested that taurine can be a potential clinical application in tumor therapy. In addition, with the in-depth study of different biological functions of taurine, we found that many systemic diseases are associated with taurine. In this review, the research progress of taurine’s antitumor effect is briefly summarized including the in vivo and in vitro studies in our laboratory.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Akt:
-
Phosphorylated protein kinase B
- AOM:
-
Azomethane
- CDDP:
-
Cisplatin
- COX-2:
-
Cyclooxygenase
- CTX:
-
Cyclophosphamide
- DOX:
-
Doxorubicin
- FAS:
-
Fatty acid synthase
- IFO:
-
Ifosfamide
- MST1:
-
Human mammalian sterile 20-like kinases 1
- PTEN:
-
Phosphatase and tensin homolog deleted from chromosome 10
- PUMA:
-
p53-upregulated modulator of apoptosis
- QOL:
-
Quality of life
- TauT:
-
Taurine transporter
- YAP:
-
Caspase-3 and downregulated yes-associated protein
References
Badary OA (1998) Taurine attenuates fanconi syndrome induced by ifosfamide without compromising its antitumor activity. Oncol Res 10(7):355–360
Cossu F, Milani M, Mastrangelo E, Lecis D (2019) Targeting the BIR domains of inhibitor of apoptosis (IAP) proteins in cancer treatment. Comput Struct Biotechnol J 17:142–150
El Agouza IM, Eissa SS, El Houseini MM, El-Nashar DE, Abd El Hameed OM (2011) Taurine: a novel tumor marker for enhanced detection of breast cancer among female patients. Angiogenesis 14(3):321–330
El Idrissi A, Boukarrou L, L’Amoreaux W (2009) Taurine supplementation and pancreatic remodeling. Adv Exp Med Biol 643:353–358
Gaucher D, Arnault E, Husson Z, Froger N, Dubus E, Gondouin P, Dherbecourt D, Degardin J, Simonutti M, Fouquet S, Benahmed MA, Elbayed K, Namer IJ, Massin P, Sahel JA, Picaud S (2012) Taurine deficiency damages retinal neurones: cone photoreceptors and retinal ganglion cells. Amino Acids 43(5):1979–1993
Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, Christoffersson J, Chaabane W, Moghadam AR, Kashani HH, Hashemi M, Owji AA, Los MJ (2014) Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol 112:24–49
Hassan M, Watari H, AbuAlmaaty A, Ohba Y, Sakuragi N (2014) Apoptosis and molecular targeting therapy in cancer. Biomed Res Int 2014:150845
He F, Ma N, Midorikawa K, Hiraku Y, Oikawa S, Zhang Z, Huang G, Takeuchi K, Murata M (2018) Taurine exhibits an apoptosis-inducing effect on human nasopharyngeal carcinoma cells through PTEN/Akt pathways in vitro. Amino Acids 50(12):1749–1758
He F, Ma N, Midorikawa K, Hiraku Y, Oikawa S, Mo Y, Zhang Z, Takeuchi K, Murata M (2019) Anti-cancer mechanisms of taurine in human nasopharyngeal carcinoma cells. Adv Exp Med Biol 1155:533–541
Ibrahim HM, Abdel Ghaffar FR, El-Elaimy IA, Gouida MS, Abd El Latif HM (2018) Antitumor and immune-modulatory efficacy of dual-treatment based on levamisole and/or taurine in Ehrlich ascites carcinoma-bearing mice. Biomed Pharmacother 106:43–49
Ito T, Oishi S, Takai M, Kimura Y, Uozumi Y, Fujio Y, Schaffer SW, Azuma J (2010) Cardiac and skeletal muscle abnormality in taurine transporter-knockout mice. J Biomed Sci 17(Suppl 1):S20
Ito T, Schaffer SW, Azuma J (2011) The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids 42(5):1529–1539
Johnson-Arbor K, Dubey R (2021) Doxorubicin. In: StatPearls (Internet). StatPearls Publishing, Treasure Island
Khalil RM, Abdo WS, Saad A, Khedr EG (2017) Muscle proteolytic system modulation through the effect of taurine on mice bearing muscular atrophy. Mol Cell Biochem 444(1–2):161–168
Kilb W, Fukuda A (2017) Taurine as an essential neuromodulator during perinatal cortical development. Front Cell Neurosci 11:328
Kim T, Kim AK (2013) Taurine enhances anticancer activity of cisplatin in human cervical cancer cells. Adv Exp Med Biol 776:189–198
Kim YS, Kim EK, Hwang JW, Kim WS, Shin WB, Natarajan SB, Moon SH, Jeon BT, Park PJ (2017) Taurine attenuates doxorubicin-induced toxicity on B16F10 cells. Adv Exp Med Biol 975(Pt 2):1179–1190
Li H, Ruan WJ, Liu LQ, Wan HF, Yang XH, Zhu WF, Yu LH, Zhang XL, Wan FS (2019) Impact of taurine on the proliferation and apoptosis of human cervical carcinoma cells and its mechanism. Chin Med J (Engl) 132(8):948–956
Maher SG, Condron CE, Bouchier-Hayes DJ, Toomey DM (2005) Taurine attenuates CD3/interleukin-2-induced T cell apoptosis in an in vitro model of activation-induced cell death (AICD). Clin Exp Immunol 139(2):279–286
Marcinkiewicz J, Kontny E (2012) Taurine and inflammatory diseases. Amino Acids 46(1):7–20
Nakanishi A, Kitagishi Y, Ogura Y, Matsuda S (2014) The tumor suppressor PTEN interacts with p53 in hereditary cancer (review). Int J Oncol 44(6):1813–1819
Pandya K, Clark GJ, Lau-Cam CA (2017) Investigation of the role of a supplementation with taurine on the effects of hypoglycemic-hypotensive therapy against diabetes-induced nephrotoxicity in rats. Adv Exp Med Biol 975(Pt 1):371–400
Puzio-Kuter AM (2011) The role of p53 in metabolic regulation. Genes Cancer 2(4):385–391
Redmond HP, Stapleton PP, Neary P, Bouchier-Hayes D (1998) Immunonutrition: the role of taurine. Nutrition 14(7–8):599–604
Refai NS, Louka ML, Halim HY, Montasser I (2019) Long non-coding RNAs (CASC2 and TUG1) in hepatocellular carcinoma: clinical significance. J Gene Med 21(9):e3112
Sadzuka Y, Matsuura M, Sonobe T (2009) The effect of taurine, a novel biochemical modulator, on the antitumor activity of doxorubicin. Biol Pharm Bull 32(9):1584–1587
Schaffer SW, Jong CJ, Ramila KC, Azuma J (2010) Physiological roles of taurine in heart and muscle. J Biomed Sci 17(Suppl 1):S2
Shimada K, Jong CJ, Takahashi K, Schaffer SW (2015) Role of ROS production and turnover in the antioxidant activity of taurine. Adv Exp Med Biol 803:581–596
Songbo M, Lang H, Xinyong C, Bin X, Ping Z, Liang S (2019) Oxidative stress injury in doxorubicin-induced cardiotoxicity. Toxicol Lett 307:41–48
Taha Z, Janse van Rensburg HJ, Yang X (2018) The hippo pathway: immunity and cancer. Cancers (Basel) 10(4):94
Tang Y, Choi EJ, Cheong SH, Hwang YJ, Arokiyaraj S, Park PJ, Moon SH, Kim EK (2015) Effect of taurine on prostate-specific antigen level and migration in human prostate cancer cells. Adv Exp Med Biol 803:203–214
Tsunekawa M, Wang S, Kato T, Yamashita T, Ma N (2017) Taurine administration mitigates cisplatin induced acute nephrotoxicity by decreasing DNA damage and inflammation: an immunocytochemical study. Adv Exp Med Biol 975(Pt 2):703–716
Tu S, Zhang XL, Wan HF, Xia YQ, Liu ZQ, Yang XH, Wan FS (2018) Effect of taurine on cell proliferation and apoptosis human lung cancer A549 cells. Oncol Lett 15(4):5473–5480
Vanitha MK, Anandakumar P, Sakthisekaran D (2018) Taurine abrogates mammary carcinogenesis through induction of apoptosis in Sprague-Dawley rats. J Biochem Mol Toxicol 32(10):e22204
Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ (2011) Natural innate and adaptive immunity to cancer. Annu Rev Immunol 29:235–271
Wang G, Ma N, He F, Kawanishi S, Kobayashi H, Oikawa S, Murata M (2020) Taurine attenuates carcinogenicity in ulcerative colitis-colorectal cancer mouse model. Oxidative Med Cell Longev 2020:7935917
Zhang X, Du W, Shen F, Wang J (1997) Research on effects of taurine on the transplanted tumor of mice. Wei Sheng Yan Jiu 26(5):321–324
Zhang X, Lu H, Wang Y, Liu C, Zhu W, Zheng S, Wan F (2014a) Taurine induces the apoptosis of breast cancer cells by regulating apoptosis-related proteins of mitochondria. Int J Mol Med 35(1):218–226
Zhang X, Tu S, Wang Y, Xu B, Wan F (2014b) Mechanism of taurine-induced apoptosis in human colon cancer cells. Acta Biochim Biophys Sin Shanghai 46(4):261–272
Zhang XD, Sun P, Zhu DL, Xie N (2014c) Inhibitory effect of taurine in hypoxia-induced rat pulmonary artery smooth muscle cell proliferation and signal transduction mechanism. Zhongguo Zhong Yao Za Zhi 39(10):1902–1907
Zhang W, Liu K, Pei Y, Ma J, Tan J, Zhao J (2018) Mst1 regulates non-small cell lung cancer A549 cell apoptosis by inducing mitochondrial damage via ROCK1/Factin pathways. Int J Oncol 53(6):2409–2422
Zhao N, Wang L, Mou HY, Liang M, Yue W (2009) Synergism and attenuation effects of taurine on cyclophosphamide. Ai Zheng 28(3):244–248
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ma, N., He, F., Kawanokuchi, J., Wang, G., Yamashita, T. (2022). Taurine and Its Anticancer Functions: In Vivo and In Vitro Study. In: Schaffer, S.W., El Idrissi, A., Murakami, S. (eds) Taurine 12. Advances in Experimental Medicine and Biology, vol 1370. Springer, Cham. https://doi.org/10.1007/978-3-030-93337-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-93337-1_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-93336-4
Online ISBN: 978-3-030-93337-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)